SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 8.00
+0.15 (1.91%)
At close: Mar 25, 2026
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 20.73 million as of March 25, 2026. Its market cap has decreased by -63.48% in one year.
Market Cap
20.73M
Enterprise Value
16.95M
Revenue
4.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.00
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 20.73M, an increase of 31.82%. That is a compound annual growth rate of 3.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 20.73M | -49.13% |
| Dec 31, 2025 | 40.76M | -3.56% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 49.79M |
| hVIVO | 44.90M |
| Poolbeg Pharma | 29.09M |
| ImmuPharma | 23.88M |
| Arecor Therapeutics | 23.60M |
| Sareum Holdings | 21.40M |
| Aptamer Group | 17.53M |
| Fusion Antibodies | 14.38M |